Skip to content
  • Sunday, 26 July 2026
  • 2:50 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Interleaved bond frustration in a triangular lattice antiferromagnet.
Advanced Materials Science

Interleaved bond frustration in a triangular lattice antiferromagnet.

Nila Kartika Wati Apr 18, 2026 0

This research, led by Stephen Wilson and his team at the University of California, Santa Barbara (UCSB), represents a significant…

Read More
Advanced Materials Science

Interleaved bond frustration in a triangular lattice antiferromagnet

Nila Kartika Wati Mar 25, 2026 0

In the sophisticated laboratories of the University of California, Santa Barbara, a team of materials scientists led by Stephen Wilson…

Read More
Advanced Materials Science

Interleaved bond frustration in a triangular lattice antiferromagnet

Nila Kartika Wati Mar 18, 2026 0

In the specialized field of condensed matter physics, the quest to understand and manipulate the fundamental building blocks of matter…

Read More
Breast cancers that disseminate to bone marrow acquire aggressive phenotypes through CX43-related tumor-stroma tunnelsHow to Write to Files in Python: A Beginner’s GuideThe Mysterious Golden Orb Unearthed in the Deep Sea Finally Reveals Its Identity After a Two-Year Scientific OdysseyAI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ